187 related articles for article (PubMed ID: 21220309)
1. Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response.
Calderon B; Carrero JA; Miller MJ; Unanue ER
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1567-72. PubMed ID: 21220309
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.
Calderon B; Carrero JA; Miller MJ; Unanue ER
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1561-6. PubMed ID: 21220322
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.
Calderon B; Suri A; Pan XO; Mills JC; Unanue ER
J Immunol; 2008 Nov; 181(10):6964-74. PubMed ID: 18981116
[TBL] [Abstract][Full Text] [Related]
4. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide transcriptional analyses of islet-specific CD4+ T cells identify Idd9 genes controlling diabetogenic T cell function.
Berry GJ; Frielle C; Luu T; Salzberg AC; Rainbow DB; Wicker LS; Waldner H
J Immunol; 2015 Mar; 194(6):2654-63. PubMed ID: 25672752
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression.
Ren G; Zhao X; Zhang L; Zhang J; L'Huillier A; Ling W; Roberts AI; Le AD; Shi S; Shao C; Shi Y
J Immunol; 2010 Mar; 184(5):2321-8. PubMed ID: 20130212
[TBL] [Abstract][Full Text] [Related]
7. IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4
Scott NA; Zhao Y; Krishnamurthy B; Mannering SI; Kay TWH; Thomas HE
Front Immunol; 2018; 9():2800. PubMed ID: 30555479
[TBL] [Abstract][Full Text] [Related]
8. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.
Lennon GP; Bettini M; Burton AR; Vincent E; Arnold PY; Santamaria P; Vignali DA
Immunity; 2009 Oct; 31(4):643-53. PubMed ID: 19818656
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells.
Yi Z; Li L; Garland A; He Q; Wang H; Katz JD; Tisch R; Wang B
Eur J Immunol; 2012 Aug; 42(8):2010-8. PubMed ID: 22865049
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates.
Martin S; Hibino T; Faust A; Kleemann R; Kolb H
J Autoimmun; 1996 Oct; 9(5):637-43. PubMed ID: 8933279
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
12. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma affects homing of diabetogenic T cells.
Savinov AY; Wong FS; Chervonsky AV
J Immunol; 2001 Dec; 167(11):6637-43. PubMed ID: 11714835
[TBL] [Abstract][Full Text] [Related]
14. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
[TBL] [Abstract][Full Text] [Related]
15. TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential.
Bettini M; Blanchfield L; Castellaw A; Zhang Q; Nakayama M; Smeltzer MP; Zhang H; Hogquist KA; Evavold BD; Vignali DA
J Immunol; 2014 Jul; 193(2):571-9. PubMed ID: 24943217
[TBL] [Abstract][Full Text] [Related]
16. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
Aboumrad E; Madec AM; Thivolet C
Clin Exp Immunol; 2007 Jun; 148(3):432-9. PubMed ID: 17374136
[TBL] [Abstract][Full Text] [Related]
17. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
[TBL] [Abstract][Full Text] [Related]
18. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
19. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
20. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
